Discovery of Potential Biomarkers That Discriminate Early Stage NSCLC from Controls by Non-Targeted Metabolomics Profiling

被引：0

作者：

Kim, J. ^{[1
]}

Balshaw, R. ^{[2
]}

Trevena, C. ^{[3
]}

Banerji, S. ^{[4
]}

Murphy, L. ^{[5
]}

Dawe, D. ^{[4
]}

Tan, L. ^{[6
]}

Srinathan, S. ^{[6
]}

Buduhan, G. ^{[6
]}

Kidane, B. ^{[6
]}

Qing, G. ^{[7
]}

Domaratzki, M. ^{[3
]}

Aliani, M. ^{[8
]}

机构：

[1] Cancercare Manitoba, Radiat Oncol, Winnipeg, MB, Canada

[2] Univ Manitoba, Ctr Hlth Innovat, Winnipeg, MB, Canada

[3] Univ Manitoba, Comp Sci, Winnipeg, MB, Canada

[4] Cancercare Manitoba, Med Oncol, Winnipeg, MB, Canada

[5] Univ Manitoba, Biochem & Med Genet, Winnipeg, MB, Canada

[6] Univ Manitoba, Surg, Winnipeg, MB, Canada

[7] Univ Manitoba, Pathol, Winnipeg, MB, Canada

[8] Univ Manitoba, Food & Human Nutr Sci, Winnipeg, MB, Canada

来源：

关键词：

Biomarker; early detection; metabolomics;

D O I：

10.1016/j.jtho.2019.08.1710

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.11-10

引用

页码：S795 / S796

页数：2